microdosing semaglutide chart Weight Loss Dosage Medical Weight Loss Education Materials

Clinical trials demonstrate that it delivers weight loss efficacy comparable to injectable therapies like Wegovy

In short, semaglutide is a GLP-1 receptor agonist that works by reducing hunger and cravings, increasing satiety, slowing gastric emptying and intestinal transit time, and increasing glucose-dependent insulin release from the pancreas

The trial met its primary endpoint, demonstrating that semaglutide 7.2 mg led to significantly greater weight loss at week 72 compared to placebo

This can contribute to osteoporosis, a condition characterized by brittle bones that are prone to fractures

Approximately half of the participants had multiple weight-related comorbidities, most commonly hypertension and dyslipidaemia [22]

Wegovy injections are better if you prefer once-weekly treatment and want fewer rules around food, drink and timing